NEUROLEAP Trademark

Trademark Overview


On Sunday, October 29, 2023, a trademark application was filed for NEUROLEAP with the United States Patent and Trademark Office. The USPTO has given the NEUROLEAP trademark a serial number of 98245330. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2024. This trademark is owned by SolaVix Health, LLC. The NEUROLEAP trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements
neuroleap

General Information


Serial Number98245330
Word MarkNEUROLEAP
Filing DateSunday, October 29, 2023
Status700 - REGISTERED
Status DateTuesday, September 17, 2024
Registration Number7509841
Registration DateTuesday, September 17, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesDietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 29, 2023
Primary Code005
First Use Anywhere DateWednesday, November 15, 2023
First Use In Commerce DateSaturday, January 6, 2024

Trademark Owner History


Party NameSolaVix Health, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBeverly Hills, CA 90209

Party NameSolaVix Health, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeverly Hills, CA 90209

Party NameSolaVix Health, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeverly Hills, CA 90209

Trademark Events


Event DateEvent Description
Wednesday, June 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 20, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, August 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, October 29, 2023NEW APPLICATION ENTERED
Tuesday, January 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Monday, May 20, 2024USE AMENDMENT FILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 17, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 12, 2024ASSIGNED TO EXAMINER
Tuesday, September 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords


neuroleap supplements dietary